About the Company
We do not have any company description for Passage BIO, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Passage BIO, Inc.
Passage Bio, Inc. (PASG) Q4 2022 Earnings Call Transcript
Passage Bio, Inc. (NASDAQ:PASG) Q4 2022 Earnings Conference Call March 6, 2023 8:30 AM ETCompany ParticipantsStuart Henderson - Vice President, Corporate ...
Passage Bio, Inc. (PASG) Is Up 24.26% in One Week: What You ... - Nasdaq
Shares of Passage Bio, Inc. Have increased 144.29% over the past quarter, and have gained 30.53% in the last year. On the other hand, the S&P 500 has only moved 12.57% and 27.72%, respectively.
Passage Bio Inc. Advanced Charts | PASG | Barron's
Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved ...
Passage Bio, Inc. (PASG) Is Up 24.26% in One Week: What You Should Know
Shares of Passage Bio, Inc. Have increased 144.29% over the past quarter, and have gained 30.53% in the last year. On the other hand, the S&P 500 has only moved 12.57% and 27.72%, respectively.
Passage Bio Reports Q2 2025 Progress and Financials
Passage Bio, Inc. ( ($PASG) ) has released its Q2 earnings. Here is a breakdown of the information Passage Bio, Inc. presented to its investors.
Passage Bio Inc. Research & Ratings | PASG | Barron's
Passage Bio Inc. research and ratings by Barron's. View PASG revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
What Kind Of Investors Own Most Of Passage Bio, Inc. (NASDAQ:PASG)?
Every investor in Passage Bio, Inc. (NASDAQ:PASG) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of younger, smaller, companies while huge companies tend ...
PASG Stock Quote Price and Forecast | CNN
View Passage Bio, Inc. PASG stock quote prices, financial information, real-time forecasts, and company news from CNN.
Passage Bio, Inc.
View Passage Bio, Inc. PASG stock quote prices, financial information, real-time forecasts, and company news from CNN.
Passage Bio, Inc. (PASG) CEO Bruce Goldsmith on Q3 2021 Results ...
Passage Bio, Inc. (NASDAQ:PASG) Q3 2021 Results Conference Call November 4, 2021 8:30 AM ETCompany ParticipantsStuart Henderson - VP, IR and Strategic ...
Passage Bio to Host First of a Series of 2021 Virtual R&D Events on ...
PHILADELPHIA, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous ...
Similar Companies
Loading the latest forecasts...